Articles On Cann Group (ASX:CAN)

From powdered milk to multivitamins to fresh fruit, Australian and New Zealand products command a health premium in Asian markets but can the medical cannabis industry leverage this 'clean green' image and follow suit?  Cann Group (ASX: C...

The Cannabis sector is comparatively broad than the expectations of various market research houses, boutique research house or asset managers etc. The prevailing status of cannabis legalisation gradually appears positive, but the market wou...

Marijuana vs Liquor in the United States     Recent studies have revealed that the consumer demands in Cannabis and alcohol market space are not as correlated as was anticipated by the industry participants with the legalisation of marijuan...

Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the...

Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the...

One area of the share market that is performing better than most on Thursday is the cannabis industry. A number of cannabis-related shares are trading notably higher today. Two in particular that have caught the eye are listed below. Here’s...

Elixinol Global (ASX:EXL) has raised $50m from professional investors, making it the second largest capital raising among Australian pot stocks since Cann Group (ASX:CAN) took $60m in 2017 to build its growing facilities. Elixinol raised $4...

Despite IG Markets forcing its users to sell the 19 global pot stocks on its books by 24 May, Australian pot stocks have generally been racking up the good news. IG were spooked by potential legal ramifications, mostly affecting UK investor...